Vazaios, K.; Hernández López, P.; Aarts-Riemens, T.; Daudeij, A.; Kemp, V.; Hoeben, R.C.; Straetemans, T.; Hulleman, E.; Calkoen, F.G.; van der Lugt, J.;
et al. Unusual Partners: γδ-TCR-Based T Cell Therapy in Combination with Oncolytic Virus Treatment for Diffuse Midline Gliomas. Int. J. Mol. Sci. 2025, 26, 2167.
https://doi.org/10.3390/ijms26052167
AMA Style
Vazaios K, Hernández López P, Aarts-Riemens T, Daudeij A, Kemp V, Hoeben RC, Straetemans T, Hulleman E, Calkoen FG, van der Lugt J,
et al. Unusual Partners: γδ-TCR-Based T Cell Therapy in Combination with Oncolytic Virus Treatment for Diffuse Midline Gliomas. International Journal of Molecular Sciences. 2025; 26(5):2167.
https://doi.org/10.3390/ijms26052167
Chicago/Turabian Style
Vazaios, Konstantinos, Patricia Hernández López, Tineke Aarts-Riemens, Annet Daudeij, Vera Kemp, Rob C. Hoeben, Trudy Straetemans, Esther Hulleman, Friso G. Calkoen, Jasper van der Lugt,
and et al. 2025. "Unusual Partners: γδ-TCR-Based T Cell Therapy in Combination with Oncolytic Virus Treatment for Diffuse Midline Gliomas" International Journal of Molecular Sciences 26, no. 5: 2167.
https://doi.org/10.3390/ijms26052167
APA Style
Vazaios, K., Hernández López, P., Aarts-Riemens, T., Daudeij, A., Kemp, V., Hoeben, R. C., Straetemans, T., Hulleman, E., Calkoen, F. G., van der Lugt, J., & Kuball, J.
(2025). Unusual Partners: γδ-TCR-Based T Cell Therapy in Combination with Oncolytic Virus Treatment for Diffuse Midline Gliomas. International Journal of Molecular Sciences, 26(5), 2167.
https://doi.org/10.3390/ijms26052167